Evertt Laboratories Acquires Quinnova Pharmaceuticals

News
Article

Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.

Everett Laboratories, a privately held specialty pharmaceutical company and a subsidiary of Exeltis, headquarted in Madrid, Spain, has acquired Quinnova Pharmaceuticals, from parent company Amneal Enterprises.

The acquisition will result in the strategic expansion of Everett into the US dermatology market.

Summary: Everett Laboratories

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content